Favipiravir reported to have efficacy in treating COVID-19

Favipiravir reported to have efficacy in treating COVID-19

The article below was published in The Guardian on March 18, 2020. Link Here.

DisclaimerThese links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by the Stanford University School of Medicine of any of the products, services or opinions of the corporation or organization or individual. The Stanford University School of Medicine bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links. Please contact the external site for answers to questions regarding their content.

Japanese flu drug 'clearly effective' in treating coronavirus, says China

Medical authorities in China have said a drug used in Japan to treat new strains of influenza appeared to be effective in coronavirus patients, Japanese media said on Wednesday...

Patients who were given the medicine in Shenzhen turned negative for the virus after a median of four days after becoming positive, compared with a median of 11 days for those who were not treated with the drug, public broadcaster NHK said.